Rapidly Growing Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Using Adaptive Volumetric Modulated Arc Therapy Followed by Durvalumab Maintenance: A Case Report

Keisuke Sakai; Kota Fujii; Hideki Hanazawa; Mami Sakai; Yurie Tsutsumi; Yasushi Fukuda; Yoko Akaike; Kenji Notohara; Satoshi Itasaka

doi:10.12659/AJCR.934767

31 January 2022 : Case report Japan

Rapidly Growing Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Using Adaptive Volumetric Modulated Arc Therapy Followed by Durvalumab Maintenance: A Case Report

Unusual or unexpected effect of treatment

Keisuke Sakai

^1ABCDEF, Kota Fujii

^1ADEF, Hideki Hanazawa^1ADEF, Mami Sakai^1EF, Yurie Tsutsumi^1E, Yasushi Fukuda^2E, Yoko Akaike^3BE, Kenji Notohara^3E, Satoshi Itasaka^1ADEF*

DOI: 10.12659/AJCR.934767

Am J Case Rep 2022; 23:e934767

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. A–C, dose distribution of the initial plan; D–F, dose distribution of the second plan adapted to tumor progression; G–I, dose distribution of the third plan adapted to tumor shrinkage. The colored lines indicate isodoses.

Back to the Article

Rapidly Growing Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Using Adaptive Volumetric Modulated Arc Therapy Followed by Durvalumab Maintenance: A Case Report

Your Privacy